These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease. Cucchiara S; Staiano A; Boccieri A; De Stefano M; Capozzi C; Manzi G; Camerlingo F; Paone FM Gut; 1990 Jan; 31(1):21-5. PubMed ID: 2180792 [TBL] [Abstract][Full Text] [Related]
3. The effect of mosapride on oesophageal motor function and acid reflux in patients with gastro-oesophageal reflux disease. Ruth M; Finizia C; Cange L; Lundell L Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1115-21. PubMed ID: 14501621 [TBL] [Abstract][Full Text] [Related]
4. The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients. Van Herwaarden MA; Samsom M; Van Nispen CH; Verlinden M; Smout AJ Aliment Pharmacol Ther; 2000 Apr; 14(4):453-62. PubMed ID: 10759625 [TBL] [Abstract][Full Text] [Related]
5. Cisapride in the treatment of gastro-oesophageal reflux disease. Robertson CS; Evans DF; Ledingham SJ; Atkinson M Aliment Pharmacol Ther; 1993 Apr; 7(2):181-90. PubMed ID: 8485271 [TBL] [Abstract][Full Text] [Related]
6. Effect of cisapride on nocturnal transient lower oesophageal sphincter relaxations and nocturnal gastro-oesophageal reflux in patients with oesophagitis: a double-blind, placebo-controlled study. Pehlivanov N; Sarosiek I; Whitman R; Olyaee M; McCallum R Aliment Pharmacol Ther; 2002 Apr; 16(4):743-7. PubMed ID: 11929392 [TBL] [Abstract][Full Text] [Related]
7. Cisapride in gastro-oesophageal reflux disease: effects on oesophageal motility and intra-oesophageal pH. Wienbeck M; Li Q Scand J Gastroenterol Suppl; 1989; 165():13-8; discussion 27-8. PubMed ID: 2690320 [TBL] [Abstract][Full Text] [Related]
9. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study. Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947 [TBL] [Abstract][Full Text] [Related]
10. Influence of cisapride on food-stimulated gastro-oesophageal reflux: a radiological study. Gelineck J; Aksglade K; Funch-Jensen P; Thommesen P Rontgenblatter; 1990 Aug; 43(8):352-4. PubMed ID: 2204995 [TBL] [Abstract][Full Text] [Related]
11. The effect of cisapride on oesophageal motility and lower sphincter function in patients with gastro-oesophageal reflux disease. Finizia C; Lundell L; Cange L; Ruth M Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):9-14. PubMed ID: 11782569 [TBL] [Abstract][Full Text] [Related]
12. Cisapride: influence on oesophageal and gastric emptying and gastro-oesophageal reflux in patients with reflux oesophagitis. Collins BJ; Spence RA; Ferguson R; Laird J; Love AH Hepatogastroenterology; 1987 Jun; 34(3):113-6. PubMed ID: 3301606 [TBL] [Abstract][Full Text] [Related]
14. Effect of cisapride on the gastro-oesophageal function in normal human subjects. Wallin L; Kruse-Andersen S; Madsen T; Boesby S Digestion; 1987; 37(3):160-5. PubMed ID: 3653529 [TBL] [Abstract][Full Text] [Related]
15. Effects of cisapride, a new gastrointestinal prokinetic substance, on interdigestive and postprandial motor activity of the distal oesophagus in man. Smout AJ; Bogaard JW; Grade AC; ten Thije OJ; Akkermans LM; Wittebol P Gut; 1985 Mar; 26(3):246-51. PubMed ID: 3882526 [TBL] [Abstract][Full Text] [Related]
16. Cisapride inhibits meal-stimulated gastric acid secretion and post-prandial gastric acidity in subjects with gastro-oesophageal reflux disease. Gardner JD; Rodriguez-Stanley S; Robinson M; Miner PB Aliment Pharmacol Ther; 2002 Oct; 16(10):1819-29. PubMed ID: 12269977 [TBL] [Abstract][Full Text] [Related]
17. The efficacy of a 40-mg extended-release formulation of cisapride in the treatment of patients with gastro-oesophageal reflux. Katschinski M; Schirra J; Arnold R Aliment Pharmacol Ther; 2000 Jan; 14(1):113-22. PubMed ID: 10632654 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of gastro-oesophageal reflux in cystic fibrosis. Cucchiara S; Santamaria F; Andreotti MR; Minella R; Ercolini P; Oggero V; de Ritis G Arch Dis Child; 1991 May; 66(5):617-22. PubMed ID: 2039253 [TBL] [Abstract][Full Text] [Related]
19. The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease. van Herwaarden MA; Samsom M; Rydholm H; Smout AJ Aliment Pharmacol Ther; 2002 Sep; 16(9):1655-62. PubMed ID: 12197845 [TBL] [Abstract][Full Text] [Related]
20. Cisapride for gastro-oesophageal reflux and peptic oesophagitis. Cucchiara S; Staiano A; Capozzi C; Di Lorenzo C; Boccieri A; Auricchio S Arch Dis Child; 1987 May; 62(5):454-7. PubMed ID: 3300570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]